🇬🇧·8h agoIndustry
GSK’s momelotinib granted Orphan Drug Designations in the US and EU for VEXAS syndrome
Publisher
G
GSK News
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- GSK News
- Region
- UK
- Scope
- Industry
- Published
- June 12, 2026
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on gsk.com
Leave the platform to read the original full article on the publisher site.
Source: GSK News
Scope: Industry
Related coverage
More related coverage
Certara·7h ago
Certara Integrates D360™ with Secondary Intelligence™ Software to Enhance Predicting Drug Safety Risk
AbbVie News·13h ago
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
UC Davis Health·13h ago
School of Nursing honors graduates and certificate recipients at commencement
UC Davis Health·13h ago